STORZ MEDICAL AG

STORZ MEDICAL AG is a Swiss-based world leader in non-invasive shock wave therapy systems and lithotripters, established in 1987. The company designs and manufactures high-precision medical devices for Extracorporeal Shock Wave Lithotripsy (SWL), Extracorporeal Shock Wave Therapy (ESWT), and Extracorporeal Magnetotransduction Therapy (EMTT). Its products serve multiple clinical disciplines including urology (kidney and ureteral stone treatment), orthopedics and sports medicine (musculoskeletal disorders), cardiology (Cardiac Shock Wave Therapy for myocardial revascularization), neurology (Transcranial Pulse Stimulation for Alzheimer's disease), dermatology, and veterinary medicine. The MODULITH® SLX-F2 is FDA-approved for pediatric kidney stone therapy in the USA. With over 100,000 installed systems in 130+ countries, STORZ MEDICAL offers both focused and radial shock wave modalities, complemented by vibration therapy (V-ACTOR®) and integrated software solutions. All devices carry CE, FDA, and MDSAP certifications.